Skip to main content
NMAD logo

NMAD

Lixte Biotechnology Holdings, Inc.
$6.93 +0.83 (+13.61%) At close · Jul 8
Market Cap
$85.81M
Shares
12,382,944

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.93 Open$6.15 Day$5.99–6.95 52W$2.30–8.38 Avg vol 30d453K Short int386K · 3.1% float · 1.0d Short vol57% DataJan 2020–Jul 2026 Filing10-Q · May 14
Equibles Rating blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 16.9 · calm Equity put/call 0.86
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +60%
above
Price vs 50-day avg +15%
above
RSI (14) 51
neutral
MACD trend Negative
52-week position 76%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +4%
trailing
6-month return +107%
trailing
YTD return +76%
this year
Relative strength +100%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $6 › 200d $4 — 50d above 200d
Institutional flow Accumulating
1 of 14 funds reported for Jun 30 · net +44.6K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.12% of float · ▲ +56.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
14 holders — mid 3-yr range
Squeeze score 60
elevated · 0–100
Fundamentals
Excellent
EPS growth +21%
Y/Y
Balance sheet $4.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 115%
annualized · 1-yr
Max drawdown −59%
past year
ATR 12.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 14, 2026

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+60% Bullish
Price vs 50-day avg
+15% Bullish
RSI (14)
51 Neutral
MACD trend
Negative Bearish
52-week position
76% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $6 › 200d $4 — 50d above 200d
Institutional flow Accumulating
1 of 14 funds reported for Jun 30 · net +44.6K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.12% of float · ▲ +56.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
14 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $2 Now $7 · 76% 52-wk high $8
vs 200-day avg +60% vs 50-day avg +15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Electrical Equipment & Parts — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NMAD
Lixte Biotechnology Holdings, Inc.
this stock
$85.81M +76.3% 3.1%
CYATY
Contemporary Amperex Technology Co., Limited/ADR
$376.61B +23.8% 0.4%
ABLZF
Abb Ltd
$188.75B +37.9% +9.5% 0.1%
VRT
Vertiv Holdings Co
$122.07B +96.2% +27.7% 79.9 3.9%
BE
Bloom Energy Corp
$74.87B +192.7% +11.2% 10.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
15
% held
6.3%
Reported
1 of 14
Top holder
SCOTIA CAPITAL INC.
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
385.8K
Days to cover
1.0d
Change
+138.8K sh
View
Short Volume
Short vol %
57%
As of
Jul 9, 2026
Short Total
View
Fails to Deliver
FTD shares
4.0K
Value
$27.7K
As of
Jun 11, 2026
View
Off-Exchange
Off-exchange %
41.1%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$200.0K
Net income (FY)
$-6.1M
EPS diluted
$-1.26
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 2, 2026
This year
11
View
Exempt Offerings
Offering
$3.5M
Filed
Aug 1, 2023
View
Earnings & Events
Earnings Calls
Last call
Jan 29, 2026
View

Performance

5D 20D 120D MTD YTD
NMAD -6.6% +4.2% +107.5% -6.6% +76.3%
SPY -0.2% +0.8% +7.4% -0.2% +9.3%
vs SPY -6.4% +3.4% +100.1% -6.4% +67.0%
Key facts CIK 1335105 CUSIP 539319301 13F (30d) 2 filings 2 filers Visit website Investor relations